Left ventricular global function index as a predictor of adverse cardiovascular events in patients with acute coronary syndrome

Aim      To evaluate the prognostic significance of the left ventricular global function index (LV GFI) in patients with acute coronary syndrome (ACS) using echocardiography (EchoCG).

Material and methods             The LV GFI is an index that integrates LV cavity volumes, stroke volume, and myocardial volume. This study included 2169 patients with ACS (1340 (61.8%) men) aged 64.1±12.6 years from two observational multicenter studies, ORACLE I and ORACLE II. 1800 (83 %) cases were associated with increased concentrations of myocardial injury markers, including 826 (38.1 %) cases of ST segment elevation myocardial infarction (MI). The observation was started on the 10^th day of clinical condition stabilization and lasted for one year. EchoCG was performed with evaluation of LV GFI, which was calculated as a ratio of LV stroke volume to LV global volume. The LV global volume was calculated as a sum of mean LV cavity volume (LV end-diastolic volume + LV end-systolic volume / 2) and LV myocardial volume.

Results The main outcome of the study was all-cause death (n=193); recurrent coronary complications (n=253) were analyzed separately. The only EchoCG parameter indicating an adverse outcome during the one-year follow-up was a LV GFI decrease to below 22.6 % with a sensitivity of 72 % and a specificity of 60% (area under the curve, AUC=0.63). A LV GFI <22.6 % was an independent predictor of all-cause death (p=0.019) along with age (p=0.0001), history of MI (p=0.034), and presence of heart failure (HF) (p=0.044), diabetes mellitus (p=0.012), and peripheral atherosclerosis (p=0.001). The LV GFI <22.6 %, (p=0.044), heart rate upon discharge from the hospital (p=0.050), history of MI (p=0.006), presence of HF (p=0.014), and peripheral atherosclerosis (p=0.001) were also independent predictors for recurrent coronary complications. Decreased LV GFI was associated with the risk of fatal outcomes independent of the LV ejection fraction at baseline.

Conclusion      In patients with ACS, the left ventricular global function index is an independent predictor for all-cause death and recurrent coronary complications and may be used for risk stratification.

1. Yahud E, Tzuman O, Fink N, Goldenberg I, Goldkorn R, Peled Y, Lev E, Asher E. Trends in long-term prognosis according to left ventricular ejection fraction after acute coronary syndrome. J Cardiol. 2020 Sep;76(3):303-308. doi: 10.1016/j.jjcc.2020.03.012. Epub 2020 Apr 22. PMID: 32334901.

2. Mewton N, Opdahl A, Choi EY, Almeida AL, Kawel N, Wu CO et al. Left ventricular global function index by magnetic resonance imaging--a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the multi-ethnic study of atherosclerosis. Hypertension. 2013 Apr;61(4): 770-8. doi: 10.1161/HYPERTENSIONAHA.111.198028. Epub 2013 Feb 19.

3. Eitel I, Pöss J, Jobs A, Eitel C, de Waha S, Barkhausen J et al. Left ventricular global function index assessed by cardiovascular magnetic resonance for the prediction of cardiovascular events in ST-elevation myocardial infarction. J Cardiovasc Magn Reson. 2015 Jul 16;17:62. doi: 10.1186/s12968-015-0161-x.

4. Reinstadler SJ, Klug G, Feistritzer HJ, Kofler M, Pernter B, Göbel G et al. Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction. Eur Heart J Cardiovasc Imaging. 2016 Feb;17(2):169-76. doi: 10.1093/ehjci/jev129. Epub 2015 Jun 7

5. Nwabuo CC, Moreira HT, Vasconcellos HD et al. Left ventricular global function index predicts incident heart failure and cardiovascular disease in young adults: the coronary artery risk development in young adults (CARDIA) study. Eur Heart J Cardiovasc Imaging. 2019;20(5):533‐540. doi:10.1093/ehjci/jey123

6. Zateyshchikov D.A., Guz I.O., Evdokimova M.A., Aseycheva O.Yu., Galyavich A.S., Tereshchenko S.N. et al. Treatment of patients who underwent acute coronary syndrome, according to the Russian multicenter prospective observational study. Pharmateca. 2009;12:109-13.

7. Averkova A. O., Brazhnik V. A., Koroleva O. S, Zubova E. A., Hasanov N. R.,Chichkov Yu. M. et al. Acute coronary syndrome in young patients with familial hypercholesterolemia based on the results of ORACUL II observation trial. Medical news of north caucasus. 2017. Т. 12. № 1. 5-8. http://doi.org/10.14300/mnnc.2017.12001

8. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, et al.Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003. PMID: 25559473.

9. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101(25):2981‐2988. doi:10.1161/01.cir.101.25.2981

10. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161‐1172. doi:10.1161/01.cir.81.4.1161

11. Warren SE, Royal HD, Markis JE, Grossman W, McKay RG. Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis. J Am Coll Cardiol. 1988;11(1):12‐19. doi:10.1016/0735-1097(88)90159-3

12. Grines CL, Marsalese DL, Brodie B, et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. J Am Coll Cardiol. 1998;31(5):967‐972. doi:10.1016/s0735-1097(98)00031-x

13. Ibanez , James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119‐177. doi:10.1093/eurheartj/ehx393

14. Verma A, Meris A, Skali H, et al. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovasc Imaging. 2008;1(5):582‐591. doi:10.1016/j.jcmg.2008.05.012